Leon-nanodrugs GmbH | WebDisclosure

BRIEF

published on 12/05/2024 at 10:05, 5 months 26 days ago

LEON's FR-JET Technology Validated for Advanced Nanoparticle Manufacturing

Drug Delivery Nanoparticle Manufacturing FR-JET Technology Evonik Collaboration Pharmatech Innovation
BRIEF

published on 12/05/2024 at 10:05, 5 months 26 days ago

La technologie FR-JET de LEON validée pour la fabrication avancée de nanoparticules

Administration De Médicaments Fabrication De Nanoparticules Technologie FR-JET Collaboration Evonik Innovation Dans Le Domaine Pharmaceutique
PRESS RELEASE

published on 12/05/2024 at 10:00, 5 months 26 days ago

Feasibility Study with Evonik Confirms LEON’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery
Feasibility study confirms LEON's FR-JET technology's exceptional performance in advanced nanoparticle manufacturing for drug delivery, validated by Evonik Canada Inc

Feasibility Study Drug Delivery LEON Nanoparticle Manufacturing FR-JET Technology
BRIEF

published on 08/06/2024 at 10:05, 9 months 25 days ago

Leon-nanodrugs Secures Series D Financing for Nanoencapsulation Production Systems

GMP Manufacturing Cell & Gene Therapy Series D Financing Nanoencapsulation LEON
BRIEF

published on 08/06/2024 at 10:05, 9 months 25 days ago

Leon-nanodrugs obtient un financement de série D pour ses systèmes de production de nanoencapsulation

Financement De Série D Fabrication BPF Thérapie Cellulaire Et Génique Nanoencapsulation LEON
PRESS RELEASE

published on 08/06/2024 at 10:00, 9 months 25 days ago

leon-nanodrugs secures funds in a series D financing to broaden portfolio in first single-use high throughput production systems for nanoencapsulation
leon-nanodrugs secures funds in a series D financing round to expand nanoencapsulation portfolio for genetic material & active substances, aiming for efficient GMP manufacturing

Biopharma Industry LEON-nanodrugs GMP Manufacturing Series D Financing Nanoencapsulation
BRIEF

published on 04/11/2024 at 13:05, 1 year 1 month ago

LEON-nanodrugs GmbH Advances Nanoparticle Drug Delivery Manufacturing with CMAC Collaboration

Drug Delivery Leon-nanodrugs GmbH Nanoparticle Technology CMAC Collaboration Pharmaceutical Manufacturing
BRIEF

published on 04/11/2024 at 13:05, 1 year 1 month ago

LEON-nanodrugs GmbH fait progresser la fabrication de nanoparticules pour l'administration de médicaments avec la collaboration du CMAC

L'administration De Médicaments Leon-nanodrugs GmbH Technologie Des Nanoparticules Collaboration Avec Le CMAC Fabrication Pharmaceutique
PRESS RELEASE

published on 04/11/2024 at 13:00, 1 year 1 month ago

Technical Evaluation by CMAC Introduces LEON’s Cutting-Edge Formulation Technology
Technical Evaluation by CMAC introduces LEON's cutting-edge formulation technology, revolutionizing lipid nanoparticle production for drug delivery. Joint effort with experts proves success in in-vitro and in-vivo tests

Drug Delivery Pharmaceutical Manufacturing LEON-nanodrugs CMAC Lipid Nanoparticles
PRESS RELEASE

published on 07/18/2023 at 09:00, 1 year 10 months ago

leon-nanodrugs appoints Dr. Hans Frickel as Chief Executive Officer

Published on 05/31/2025 at 06:16, 22 hours 22 minutes ago

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
Published on 05/31/2025 at 03:30, 1 day 1 hour ago

Avant Brands Inc. Announces Voting Results From 2025 Annual General Meeting of Shareholders
Published on 05/31/2025 at 01:45, 1 day 2 hours ago

GLG Life Tech Corporation Reports 2025 First Quarter Financial Results
Published on 05/30/2025 at 23:10, 1 day 5 hours ago

CORRECTION: Nextech3D.ai Migrates MAP Dynamics to AWS, Enabling Scalable AI Architecture and Accelerated Deployment
Published on 05/30/2025 at 23:00, 1 day 5 hours ago

Battery X Metals Achieves Full Capacity Recovery on a Real-World Imbalanced Battery from the #2 Out-of-Warranty Electric Vehicle Model in the United States in Preliminary Trial

View all ACCESSWIRE

Published on 05/31/2025 at 21:00, 7 hours 38 minutes ago

Leclanché annonce le dépôt d'une demande de prolongation du délai de publication du rapport annuel 2024 et la suspension temporaire de la cotation de ses actions nominatives à la SIX Swiss Exchange
Published on 05/31/2025 at 21:00, 7 hours 38 minutes ago

Leclanché SA: Leclanché announces filing of request to extend the publication deadline for the 2024 Annual Report and the temporary suspension of trading of its registered shares on SIX Swiss Exchange
Published on 05/31/2025 at 18:37, 10 hours ago

Meyer Burger files for insolvency for German subsidiaries
Published on 05/31/2025 at 14:50, 13 hours 47 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/31/2025 at 14:46, 13 hours 51 minutes ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets

View all EQS

Published on 05/30/2025 at 22:00, 1 day 6 hours ago

Information sur les comptes annuels
Published on 05/30/2025 at 22:00, 1 day 6 hours ago

Information on the Annual Financial Statements
Published on 05/30/2025 at 18:14, 1 day 10 hours ago

Emova Group - Rapport annuel de Durabilité 23/24
Published on 05/28/2025 at 23:00, 3 days 5 hours ago

Standstill Commitments to hold shares of the company
Published on 05/28/2025 at 23:00, 3 days 5 hours ago

Engagements collectifs de conservation de titres de la société

View all LES ECHOS COMFI WIRE

News